Federal lawmakers – from both sides of the aisle and in both Congressional bodies – are pushing for a means of streamlining so-called “breakthrough therapies” that involve psychedelic drugs like MDMA and psilocybin for the purpose of promoting drug research and development. As longtime Los Angeles cannabis business attorneys, we help break down what legislators…
Continue reading ›
